NASHVILLE, Tenn., Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today ...

Creatine is a popular supplement that is typically to enhance the benefits from exercise. Learn more about the positives of taking creatine beyond muscle building.

Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.

Determined Stoke City fan Paul Parsons has been clocking up the miles as he looks to score for charity after being inspired by his friend's brave daughter. The 46-year-old had this week set off from ...

Cumberland Pharmaceuticals Inc. ( CPIX) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is ...

Controversial Yemassee 'monkey farm' announces plan to house retired scientific research monkeys from other facilities in the ...

Controversial Yemassee 'monkey farm' announces plan to house retired scientific research monkeys from other facilities in the wake of federal funding cuts.

Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been ...

Trent, is supporting Muscular Dystrophy UK, the leading charity for more than 110,000 children and adults in the UK ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, taking ...